期刊论文详细信息
BioMedical Engineering OnLine
Fibroin and fibroin blended three-dimensional scaffolds for rat chondrocyte culture
Pratthana Chomchalao1  Sutatip Pongcharoen3  Manote Sutheerawattananonda2  Waree Tiyaboonchai1 
[1] Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok 65000, Thailand and the Center of Excellence for Innovation in Chemistry, Commission on Higher Education, Thailand
[2] Institute of Agricultural Technology, Suranaree University of Technology, Nakhon Ratchasima 30000, Thailand
[3] Faculty of Medicine, Naresuan University, Phitsanulok 65000, Thailand
关键词: Chondrocytes;    Scaffolds;    Gelatin;    Collagen;    Fibroin;   
Others  :  797911
DOI  :  10.1186/1475-925X-12-28
 received in 2013-01-23, accepted in 2013-04-01,  发布年份 2013
PDF
【 摘 要 】

Background

In our previous study, we successfully developed 3-D scaffolds prepared from silk fibroin (SF), silk fibroin/collagen (SF/C) and silk fibroin/gelatin (SF/G) using a freeze drying technique. The blended construct showed superior mechanical properties to silk fibroin construct. In addition, collagen and gelatin, contain RGD sequences that could facilitate cell attachment and proliferation. Therefore, in this study, the ability of silk fibroin and blended constructs to promote cell adhesion, proliferation and production of extracellular matrix (EMC) were compared.

Methods

Articular chondrocytes were isolated from rat and cultured on the prepared constructs. Then, the cell viability in SF, SF/C and SF/G scaffolds was determined by MTT assay. Cell morphology and distribution were investigated by scanning electron microscopy (SEM) and histological analysis. Moreover, the secretion of extracellular matrix (ECM) by the chondrocytes in 3-D scaffolds was assessed by immunohistochemistry.

Results

Results from MTT assay indicated that the blended SF/C and SF/G scaffolds provided a more favorable environment for chondrocytes attachment and proliferation than that of SF scaffold. In addition, scanning electron micrographs and histological images illustrated higher cell density and distribution in the SF/C and SF/G scaffolds than that in the SF scaffold. Importantly, immunohistochemistry strongly confirmed a greater production of type II collagen and aggrecan, important markers of chondrocytic phenotype, in SF blended scaffolds than that in the SF scaffold.

Conclusion

Addition of collagen and gelatin to SF solution not only improved the mechanical properties of the scaffolds but also provided an effective biomaterial constructs for chondrocyte growth and chondrocytic phenotype maintenance. Therefore, SF/C and SF/G showed a great potential as a desirable biomaterial for cartilage tissue engineering.

【 授权许可】

   
2013 Chomchalao et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140706085438719.pdf 1763KB PDF download
Figure 6. 72KB Image download
Figure 5. 55KB Image download
Figure 4. 65KB Image download
Figure 3. 96KB Image download
Figure 2. 35KB Image download
Figure 2. 35KB Image download
Figure 2. 35KB Image download
Figure 2. 35KB Image download
Figure 1. 107KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 2.

Figure 2.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】
  • [1]Marlovits S, Zeller P, Singer P, Resinger C, Vécsei V: Cartilage repair: Generations of autologous chondrocyte transplantation. Eur J Radiol 2006, 57:24-31.
  • [2]Martel-Pelletier J, Boileau C, Pelletier JP, Roughley PJ: Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheusmatol 2008, 22:351-384.
  • [3]Chung C, Burdick JA: Engineering cartilage tissue. Adv Drug Del Rev 2008, 60:243-262.
  • [4]Subramanian A, Krishnan UM, Sethuraman S: Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration. J Biomed Sci 2009, 16:108. BioMed Central Full Text
  • [5]Frenkel SR, Di Cesare PE: Scaffolds for Articular Cartilage Repair. Ann Biomed Eng 2004, 32:26-34.
  • [6]Getgood A, Bhullar TPS, Rushton N: Current concepts in articular cartilage repair. Orthopaedics and Trauma 2009, 23:189-200.
  • [7]Risbud MV, Sittinger M: Tissue engineering: advances in in vitro cartilage generation. Trends Biotechnol 2002, 20:351-356.
  • [8]Sato M, Ishihara M, Furukawa K, Kaneshiro N, Nagai T, Mitani G, Kutsuna T, Ohta N, Kokubo M, Kikuchi T: Recent technological advancements related to articular cartilage regeneration. Med Biol Eng Comput 2008, 46:735-743.
  • [9]Stoop R: Smart biomaterials for tissue engineering of cartilage. Injury 2008, 39:77-87.
  • [10]Ortinau S, Schmich J, Block S, Liedmann A, Jonas L, Weiss DG, Helm CA, Rolfs A, Frech MJ: Effect of 3D-scaffold formation on differentiation and survival in human neural progenitor cells. Biomed Eng Online 2010, 9:70. BioMed Central Full Text
  • [11]Cheung HY, Lau KT, Lu TP, Hui D: A critical review on polymer-based bio-engineered materials for scaffold development. Compos Part B-Eng 2007, 38:291-300.
  • [12]Grande D, Halberstadt C, Naughton G, Schwartz R, Manji R: Evaluation of matrix scaffolds for tissue engineering of articular cartilage grafts. J Biomed Mater Res 1997, 34:211-220.
  • [13]Janjanin S, Li WJ, Morgan MT, Shanti RM, Tuan RS: Mold-Shaped, Nanofiber Scaffold-Based Cartilage Engineering Using Human Mesenchymal Stem Cells and Bioreactor. J Surg Res 2008, 149:47-56.
  • [14]Leong KF, Cheah CM, Chua CK: Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs. Biomaterials 2003, 24:2363-2378.
  • [15]Liu C, Xia Z, Czernuszka JT: Design and development of three-dimensional scaffolds for tissue engineering. Chem Eng Res Des 2007, 85:1051-1064.
  • [16]Chang CH, Liu HC, Lin CC, Chou CH, Lin FH: Gelatin-chondroitin-hyaluronan tri-copolymer scaffold for cartilage tissue engineering. Biomaterials 2003, 24:4853-4858.
  • [17]Facchini A, Lisignoli G, Cristino S, Roseti L, De Franceschi L, Marconi E, Grigolo B: Human chondrocytes and mesenchymal stem cells grown onto engineered scaffold. Biorheology 2006, 43:471-480.
  • [18]Fan H, Liu H, Toh SL, Goh JCH: Enhanced differentiation of mesenchymal stem cells co-cultured with ligament fibroblasts on gelatin/silk fibroin hybrid scaffold. Biomaterials 2008, 29:1017-1027.
  • [19]Garcia-Fuentes M, Meinel AJ, Hilbe M, Meinel L, Merkle HP: Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering. Biomaterials 2009, 30:5068-5076.
  • [20]Lu Q, Hu K, Feng Q, Cui F: Growth of fibroblast and vascular smooth muscle cells in fibroin/collagen scaffold. Mater Sci Eng C 2009, 29:2239-2245.
  • [21]Lv Q, Hu K, Feng Q, Cui F, Cao C: Preparation and characterization of PLA/fibroin composite and culture of HepG2 (human hepatocellular liver carcinoma cell line) cells. Composites Sci Technol 2007, 67:3023-3030.
  • [22]Rohanizadeh R, Swain M, Mason R: Gelatin sponges (Gelfoam ®) as a scaffold for osteoblasts. J Mater Sci Mater Med 2008, 19:1173-1182.
  • [23]Liuyun J, Yubao L, Chengdong X: Preparation and biological properties of a novel composite scaffold of nano-hydroxyapatite/chitosan/carboxymethyl cellulose for bone tissue engineering. J Biomed Sci 2009, 16:65. BioMed Central Full Text
  • [24]Altman GH, Diaz F, Jakuba C, Calabro T, Horan RL, Chen J, Lu H, Richmond J, Kaplan DL: Silk-based biomaterials. Biomaterials 2003, 24:401-416.
  • [25]Hofmann S, Foo CT, Rossetti F, Textor M, Vunjak-Novakovic G, Kaplan DL, Merkle HP, Meinel L: Silk fibroin as an organic polymer for controlled drug delivery. J Control Release 2006, 111:219-227.
  • [26]Lu Q, Feng Q, Hu K, Cui F: Preparation of three-dimensional fibroin/collagen scaffolds in various pH conditions. J Mater Sci Mater Med 2008, 19:629-634.
  • [27]Lv Q, Feng Q, Hu K, Cui F: Three-dimensional fibroin/collagen scaffolds derived from aqueous solution and the use for HepG2 culture. Polymer 2005, 46:12662-12669.
  • [28]Aigner T, Stove J: Collagens–major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair. Adv Drug Del Rev 2003, 55:1569-1593.
  • [29]Young S, Wong M, Tabata Y, Mikos AG: Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release 2005, 109:256-274.
  • [30]Tiyaboonchai W, Chomchalao P, Pongcharoen S, Sutheerawattananonda M, Sobhon P: Preparation and characterization of blended Bombyx mori silk fibroin scaffolds. Fiber Polym 2011, 12:324-333.
  • [31]Friess W: Collagen - biomaterial for drug delivery. Eur J Pharm Biopharm 1998, 45:113-136.
  • [32]Kim UJ, Park J, Joo Kim H, Wada M, Kaplan DL: Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 2005, 26:2775-2785.
  • [33]Kang JY, Chung CW, Sung JH, Park BS, Choi JY, Lee SJ, Choi BC, Shim CK, Chung SJ, Kim DD: Novel porous matrix of hyaluronic acid for the three-dimensional culture of chondrocytes. Int J Pharm 2009, 369:114-120.
  • [34]Murphy CM, Haugh MG, O'Brien FJ: The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 2010, 31:461-466.
  • [35]Gopferich A: Mechanisms of polymer degradation and erosion. Biomaterials 1996, 17:103-114.
  • [36]Lu Q, Zhang X, Hu X, Kaplan DL: Green Process to Prepare Silk Fibroin/Gelatin Biomaterial Scaffolds. Macromol Biosci 2010, 10:289-298.
  • [37]Wang Y, Blasioli DJ, Kim H-J, Kim HS, Kaplan DL: Cartilage tissue engineering with silk scaffolds and human articular chondrocytes. Biomaterials 2006, 27:4434-4442.
  • [38]Benz K, Breit S, Lukoschek M, Mau H, Richter W: Molecular analysis of expansion, differentiation, and growth factor treatment of human chondrocytes identifies differentiation markers and growth-related genes. Biochem Biophys Res Commun 2002, 293:284-292.
  • [39]Capito RM, Spector M: Effect of expansion medium on ex vivo gene transfer and chondrogenesis in type II collagen-glycosaminoglycan scaffolds in vitro. Osteoarthr Cartilage 2006, 14:1203-1213.
  • [40]Lorenz H, Richter W: Osteoarthritis: Cellular and molecular changes in degenerating cartilage. Prog Histochem Cytochem 2006, 40:135-163.
  • [41]Schulze-Tanzil G: Activation and dedifferentiation of chondrocytes: Implications in cartilage injury and repair. Ann Anat 2009, 191:325-338.
  • [42]Miot S, Woodfield T, Daniels AU, Suetterlin R, Peterschmitt I, Heberer M, van Blitterswijk CA, Riesle J, Martin I: Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomaterials 2005, 26:2479-2489.
  • [43]Schuh E, Hofmann S, Stok K, Notbohm H, Müller R, Rotter N: Chondrocyte redifferentiation in 3D: The effect of adhesion site density and substrate elasticity. J Biomed Mater Res A 2012, 100A:38-47.
  • [44]Temenoff JS, Mikos AG: Review: tissue engineering for regeneration of articular cartilage. Biomaterials 2000, 21:431-440.
  • [45]Matmati M, Ng T, Rosenzweig D, Quinn T: Protection of Bovine Chondrocyte Phenotype by Heat Inactivation of Allogeneic Serum in Monolayer Expansion Cultures. Ann Biomed Eng 2013, 1-10.
  文献评价指标  
  下载次数:76次 浏览次数:6次